These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9838908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A phase II study of NK171 (etoposide)].
    Kimura K, Niitani H.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [Abstract] [Full Text] [Related]

  • 12. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M, Oshima S, Matsui Y, Shimokata K, Hara K, Kanda T, Shima K, Takenaka S.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [Abstract] [Full Text] [Related]

  • 13. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
    Alici S, Saip P, Eralp Y, Aydiner A, Topuz E.
    Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885
    [Abstract] [Full Text] [Related]

  • 14. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
    Akutsu M, Kano Y, Ogawa M, Miura A, Hirano M, Masaoka T, Tatsumi N.
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1867-76. PubMed ID: 11729479
    [Abstract] [Full Text] [Related]

  • 15. Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.
    Sood AK, Lush R, Geisler JP, Shahin MS, Sanders L, Sullivan D, Buller RE, Sorosky JI.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6080-5. PubMed ID: 15447993
    [Abstract] [Full Text] [Related]

  • 16. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I, Kitani T, Nagai K, Kanamaru A, Kohsaki M, Masaoka T, Shibata H, Horiuchi A, Tsubaki K, Kawagoe H.
    Gan To Kagaku Ryoho; 1985 Jul 15; 12(7):1482-6. PubMed ID: 4015122
    [Abstract] [Full Text] [Related]

  • 17. Salvage chemotherapy for recurrent spinal cord ependymona.
    Chamberlain MC.
    Cancer; 2002 Sep 01; 95(5):997-1002. PubMed ID: 12209682
    [Abstract] [Full Text] [Related]

  • 18. [TUT-7 early phase II clinical study for various solid tumors and hematologic malignancies].
    Taguchi T, Wakui A, Niitani H, Furue H, Majima H, Ota K, Ariyoshi H, Hattori T, Sugimachi K, Tsukagoshi S.
    Gan To Kagaku Ryoho; 1997 Aug 01; 24(10):1253-61. PubMed ID: 9279344
    [Abstract] [Full Text] [Related]

  • 19. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T.
    Gan To Kagaku Ryoho; 1985 Sep 01; 12(9):1801-7. PubMed ID: 2994576
    [Abstract] [Full Text] [Related]

  • 20. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
    Saeki T, Takashima S, Sano M, Horikoshi N, Miura S, Shimizu S, Morimoto K, Kimura M, Taguchi T.
    Gan To Kagaku Ryoho; 2004 Apr 01; 31(4):539-47. PubMed ID: 15114697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.